Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

XSEC:002675 株式レポート

時価総額：CN¥10.9b

Yantai Dongcheng Pharmaceutical GroupLtd 将来の成長

Future 基準チェック /36

Yantai Dongcheng Pharmaceutical GroupLtd is forecast to grow earnings and revenue by 45.9% and 13.1% per annum respectively. EPS is expected to grow by 45.8% per annum. Return on equity is forecast to be 7.6% in 3 years.

主要情報

45.9%

収益成長率

45.8%

EPS成長率

Biotechs 収益成長44.8%
収益成長率13.1%
将来の株主資本利益率7.6%
アナリストカバレッジ

Good

最終更新日01 Nov 2024

今後の成長に関する最新情報

更新なし

Recent updates

業績と収益の成長予測

XSEC:002675 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20263,906424N/A7605
12/31/20253,452327N/A6646
12/31/20243,119258N/A6486
9/30/20242,85391-167362N/A
6/30/20242,911137-280247N/A
3/31/20243,072224-340204N/A
12/31/20233,276210-235277N/A
9/30/20233,42726335490N/A
6/30/20233,603323199664N/A
3/31/20233,554302467853N/A
1/1/20233,583307607997N/A
9/30/20223,858220415986N/A
6/30/20223,851165292833N/A
3/31/20223,902140295846N/A
1/1/20223,912152413944N/A
9/30/20213,637341445788N/A
6/30/20213,5993537021,023N/A
3/31/20213,596411333618N/A
12/31/20203,419418310573N/A
9/30/20203,395214339645N/A
6/30/20203,312196149443N/A
3/31/20203,172164508760N/A
12/31/20192,993155446696N/A
9/30/20192,877366335500N/A
6/30/20192,709347458577N/A
3/31/20192,467302305457N/A
12/31/20182,333280372493N/A
9/30/20182,098228458600N/A
6/30/20181,842212N/A444N/A
3/31/20181,679185N/A339N/A
12/31/20171,596173N/A209N/A
9/30/20171,511172N/A79N/A
6/30/20171,377149N/A106N/A
3/31/20171,245145N/A106N/A
12/31/20161,158131N/A196N/A
9/30/20161,014119N/A210N/A
6/30/201690395N/A109N/A
3/31/201685283N/A103N/A
12/31/201579590N/A67N/A
9/30/201572594N/A36N/A
6/30/201572499N/A40N/A
3/31/2015727103N/A-16N/A
12/31/2014751104N/A52N/A
9/30/201478699N/A2N/A
6/30/201478396N/A-10N/A
3/31/201478291N/A66N/A
12/31/2013775101N/A-21N/A

アナリストによる今後の成長予測

収入対貯蓄率: 002675's forecast earnings growth (45.9% per year) is above the savings rate (2.9%).

収益対市場: 002675's earnings (45.9% per year) are forecast to grow faster than the CN market (25.8% per year).

高成長収益: 002675's earnings are expected to grow significantly over the next 3 years.

収益対市場: 002675's revenue (13.1% per year) is forecast to grow slower than the CN market (14% per year).

高い収益成長: 002675's revenue (13.1% per year) is forecast to grow slower than 20% per year.

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 002675's Return on Equity is forecast to be low in 3 years time (7.6%).

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y